A detailed history of Td Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Td Asset Management Inc holds 1,363,390 shares of LLY stock, worth $1.2 Billion. This represents 1.13% of its overall portfolio holdings.

Number of Shares
1,363,390
Previous 1,439,752 5.3%
Holding current value
$1.2 Billion
Previous $1.3 Billion 7.34%
% of portfolio
1.13%
Previous 1.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$772.14 - $960.02 $59 Million - $73.3 Million
-76,362 Reduced 5.3%
1,363,390 $1.21 Billion
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $28.9 Million - $36.2 Million
-39,845 Reduced 2.69%
1,439,752 $1.3 Billion
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $282 Million - $377 Million
-475,486 Reduced 24.32%
1,479,597 $1.15 Billion
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $12.5 Million - $14.7 Million
23,758 Added 1.23%
1,955,083 $1.14 Billion
Q3 2023

Oct 27, 2023

BUY
$434.7 - $599.3 $35.5 Million - $49 Million
81,692 Added 4.42%
1,931,325 $1.04 Billion
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $26.4 Million - $35.3 Million
75,366 Added 4.25%
1,849,633 $867 Million
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $144 Million - $169 Million
463,879 Added 35.4%
1,774,267 $609 Million
Q4 2022

Feb 06, 2023

SELL
$321.55 - $374.67 $16.2 Million - $18.9 Million
-50,424 Reduced 3.71%
1,310,388 $479 Million
Q3 2022

Nov 07, 2022

SELL
$296.48 - $337.87 $10.9 Million - $12.4 Million
-36,699 Reduced 2.63%
1,360,812 $449 Million
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $8.37 Million - $9.83 Million
-30,024 Reduced 2.1%
1,397,511 $453 Million
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $34.1 Million - $42.3 Million
-145,162 Reduced 9.23%
1,427,535 $409 Million
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $104 Million - $129 Million
463,989 Added 41.85%
1,572,697 $434 Million
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $8.99 Million - $11.1 Million
-40,565 Reduced 3.53%
1,108,708 $256 Million
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $57.9 Million - $74.9 Million
320,741 Added 38.71%
1,149,273 $280 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $16.9 Million - $21.9 Million
102,826 Added 14.17%
828,532 $155 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $13 Million - $17.3 Million
-100,004 Reduced 12.11%
725,706 $123 Million
Q3 2020

Nov 10, 2020

BUY
$146.22 - $169.13 $11 Million - $12.8 Million
75,472 Added 10.06%
825,710 $122 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $13.4 Million - $16.2 Million
-98,501 Reduced 11.61%
750,238 $123 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $14.5 Million - $17.9 Million
121,751 Added 16.75%
848,739 $118 Million
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $4.8 Million - $5.94 Million
44,887 Added 6.58%
726,988 $95.5 Million
Q3 2019

Nov 07, 2019

SELL
$106.79 - $116.16 $4.42 Million - $4.81 Million
-41,424 Reduced 5.73%
682,101 $76.3 Million
Q2 2019

Aug 01, 2019

SELL
$110.79 - $129.32 $31.7 Million - $37 Million
-285,814 Reduced 28.32%
723,525 $80.2 Million
Q1 2019

May 08, 2019

SELL
$111.31 - $131.02 $1.76 Million - $2.07 Million
-15,826 Reduced 1.54%
1,009,339 $131 Million
Q4 2018

Feb 01, 2019

SELL
$105.9 - $118.64 $1.05 Million - $1.18 Million
-9,933 Reduced 0.96%
1,025,165 $119 Million
Q3 2018

Nov 01, 2018

SELL
$85.86 - $107.31 $2.16 Million - $2.7 Million
-25,122 Reduced 2.37%
1,035,098 $111 Million
Q2 2018

Jul 31, 2018

SELL
$75.7 - $86.88 $3.68 Million - $4.23 Million
-48,640 Reduced 4.39%
1,060,220 $90.5 Million
Q1 2018

May 11, 2018

BUY
$74.21 - $87.6 $264,410 - $312,118
3,563 Added 0.32%
1,108,860 $85.8 Million
Q4 2017

Feb 02, 2018

SELL
$81.94 - $87.89 $1.3 Million - $1.4 Million
-15,924 Reduced 1.42%
1,105,297 $93.4 Million
Q3 2017

Nov 09, 2017

BUY
$77.07 - $85.54 $86.4 Million - $95.9 Million
1,121,221
1,121,221 $95.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $835B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.